Our mission is to globally implement breath analysis technology to provide early detection for cancers and reduce patient exposure to costly, high risk medical procedures.

We have developed a patented technology that will determine if a patient has lung cancer by analyzing a patient’s breath with parts per billion accuracy, allowing very early detection. We have studied over 700 patients. This has the potential to save a significant number of lives and save the healthcare industry significant dollars.